Treatment completed for all patients in LCT's NTCELL Phase IIb trial (New Zealand)
Living Cell Technologies Limited has completed treatment of all six patients in the third and final group of patients in the Phase IIb clinical trial of NTCELL for Parkinson’s disease, at Auckland City Hospital (New Zealand).
http://www.lctglobal.com/upload/news...0completed.pdf (hat tip to catlou at HU for the heads-up) |
All times are GMT -5. The time now is 01:46 PM. |
Powered by vBulletin Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.